Study Title
AHEP1531: Paediatric hepatic malignancy international therapeutic trial (PHITT)
Protocol ID
AHEP1531
Disease (Sub Disease)
Childhood Hepatocellular Carcinoma
Childhood Malignant Liver Neoplasm
Fibrolamellar Carcinoma
Hepatoblastoma
Hepatocellular Malignant Neoplasm, Not Otherwise Specified
Childhood Malignant Liver Neoplasm
Fibrolamellar Carcinoma
Hepatoblastoma
Hepatocellular Malignant Neoplasm, Not Otherwise Specified
Diagnosis Stage
New diagnosis
Location
NSW, QLD, VIC, WA, NZ
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
Trial Status
Temporarily Closed
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Christchurch Hospital
Starship Hospital
John Hunter Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Christchurch Hospital
Starship Hospital
Study Type
Treatment
Phase
Phase 2/3
Age Eligibility
up to 30 Years
International registry ID's
NCT03533582
| Study Title | AHEP1531: Paediatric hepatic malignancy international therapeutic trial (PHITT) |
|---|---|
| Protocol ID | AHEP1531 |
| Disease (Sub Disease) | Childhood Hepatocellular Carcinoma Childhood Malignant Liver Neoplasm Fibrolamellar Carcinoma Hepatoblastoma Hepatocellular Malignant Neoplasm, Not Otherwise Specified |
| Diagnosis Stage | New diagnosis |
| Location | NSW / QLD / VIC / WA / NZ |
| Sponsor | Children's Oncology Group |
| Collaborators | National Cancer Institute (NCI) |
| Links | https://clinicaltrials.gov/ct2/show/NCT03533582 |
| Trial Status | Temporarily Closed |
| Trial Open Date | 04/10/2018 |
| Sites | The Children's Hospital at Westmead / John Hunter Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Christchurch Hospital / Starship Hospital |
| Study Type | Treatment |
| Phase | Phase 2/3 |
| Age Eligibility | up to 30 Years |
| International registry ID's | NCT03533582 |